ストックスクリーナーアプリを入手
1.60
12.68%
0.18
Rafael Holdings Inc (RFL) 最新ニュース
Rafael Holdings Completes $25M Rights Offering - TipRanks
Rafael Holdings, Inc. Announces Final Results and Closing of Rights Offering - The Manila Times
RadNet, Inc. Acquires See-Mode Technologies for Innovation in AI-Powered Ultrasound Diagnostics - The Manila Times
Rafael Holdings Announces Final Results And Closing Of Rights Offering - marketscreener.com
Rafael CEO Backs $25M Rights Offering to Fund Critical Phase 3 Rare Disease Drug Trial - Stock Titan
Israel Defense Exports Hit Record in 2024 as Europe Demand Jumps - Bloomberg
Rafael (NYSE:RFL) Trading Up 2.6% – Still a Buy? - Defense World
Protara Therapeutics names new Chief Commercial Officer By Investing.com - Investing.com India
Protara Therapeutics Announces Appointment of William Conkling as Chief Commercial Officer - GlobeNewswire
Cancer Drug Veteran Behind Trodelvy Launch Joins Protara as Commercial Chief to Lead Market Strategy - Stock Titan
RFL stock touches 52-week low at $1.28 amid market challenges - Investing.com Australia
Rafael Holdings, Inc. Provides Update to the Description of Subscription Rights Related to its Public Warrants in Connection With its Previously Announced $25 Million Rights Offering to Support Its Commitment to the Development and Potential Launch of Trap - The Manila Times
Oruka Therapeutics Announces First Participants Dosed in Phase 1 Trial of ORKA-002, its Novel Half-life Extended Anti-IL-17A/F Antibody - The Manila Times
Rafael Holdings Rights Offering: $25M Deal Terms Revealed, May 29 Deadline Approaches - Stock Titan
Ekso Bionics reports Q1 results, plans reverse stock split - The North Bay Business Journal
Ekso Bionics Accepted into NVIDIA Connect Program - Quantisnow
Dassault Aviation Shares Continue to Drop After the Rafale Jet Shot Down - TECHi
Rafael : to Present at LD Micro Investor Conference - marketscreener.com
Rafael Holdings Enters Standby Purchase Agreement with Chairman - TipRanks
SEC Form 424B3 filed by Rafael Holdings Inc. - Quantisnow
Ekso Bionics: Q1 Earnings Snapshot - CTPost
Rafael Holdings Reports First Quarter Fiscal 2025 Financial Results - ADVFN
Rafael announces revised subscription rights in connection with offering - TipRanks
Rafael Holdings, Inc. Announces Revised Subscription Rights in Connection With its Previously Announced $25 Million Rights Offering to Support Its Commitment to the Development and Potential Launch of Trappsol® Cyclo™ - The Manila Times
Rafael Holdings, Inc. Announces Revised Subscription Rights in Connection With its Previously ... - Bluefield Daily Telegraph
Rafael Holdings Launches $25M Rights Offering: Key Dates and Terms Investors Must Know - Stock Titan
Oculis Holding AG (NASDAQ:OCS) Shares Bought by Geode Capital Management LLC - Defense World
Upcoming Stock Splits This Week (May 5 to May 9) – Stay Invested - TipRanks
Press Release Distribution & PR Platform - ACCESS Newswire
LD Micro 360 Companies: --Set to Present this Week. - ACCESS Newswire
Metric Deep Dive: Understanding Rafael Holdings Inc (RFL) Through its Ratios - DWinneX
Tronox Holdings plc: Navigating Market Fluctuations with a 857.28M Market Cap - investchronicle.com
Rafael Holdings Inc (RFL) Stock: A Year of Stock Market Ups and Downs - investchronicle.com
Rafael Holdings, Inc. Announces Proposed Terms of a $25 Million Rights Offering to Support Its Commitment to the Development and Potential Launch of Trappsol® Cyclo™ - The Manila Times
Sonoco Reports First Quarter 2025 Results - The Manila Times
Rafael Holdings Secures Future: $25M Rights Offering Powers Critical Phase 3 Drug Launch Plans - Stock Titan
Rafael Holdings, Inc. Announces Proposed Terms of a $25 Million Rights Offering to Support Its Commitment to the Development and Potential Launch of Trappsol® Cyclo - The Globe and Mail
Rafael Holdings Strengthens its Focus on the Development of Trappsol® Cyclo™ and Announces Chief Executive Officer Bill Conkling Will Be Stepping Down from His Role - The Manila Times
Rafael Holdings Strengthens its Focus on the Development of Trappsol Cyclo and Announces Chief Executive Officer Bill Conkling Will Be Stepping Down from His Role - marketscreener.com
Rafael Holdings CEO Resignation Announced - TipRanks
WillScot Announces Investor Conference Schedule for May 2025 - The Manila Times
Rafael Holdings Announces Leadership Transition Following Merger with Cyclo Therapeutics and Full Enrollment of TransportNPC™ Phase 3 Trial for Niemann-Pick Disease Treatment - Nasdaq
Rafael Holdings Strengthens its Focus on the Development of Trappsol® Cyclo™ and Announces ... - Bluefield Daily Telegraph
Rafael Holdings Pivots to Breakthrough Rare Disease Drug Development as Leadership Changes - Stock Titan
Form 8-KCurrent report - ADVFN
SEC Form S-3 filed by Ekso Bionics Holdings Inc. - Quantisnow
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CYTH, VGR, TTNP on Behalf of Shareholders - ACCESS Newswire
General Atomics Partners With Rafael to Build Precision-Guided Missile for U.S. Defense Customers - Yahoo Finance
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates GVP, AFBI, RFL, MNTX on Behalf of Shareholders - ACCESS Newswire
Autodesk announces Betsy Rafael to step down from Board of Directors - Yahoo Finance
Rafael Holdings finalizes merger with Cyclo Therapeutics By Investing.com - Investing.com South Africa
Rafael Closes Merger With Cyclo Therapeutics - MarketScreener
Rafael Holdings Completes Merger With Cyclo Therapeutics Following Shareholder Approvals - MarketScreener
Cyclo Therapeutics Merges with Rafael Holdings - TipRanks
Does Rafael Holdings (NYSE:RFL) Have A Healthy Balance Sheet? - simplywall.st
Rafael Holdings Completes Merger with Cyclo Therapeutics - TipRanks
Volatility Alert: 10 Stocks Showing High IV Percentile - The Globe and Mail
Rafael Holdings finalizes merger with Cyclo Therapeutics - Investing.com
Rafael Holdings Completes Merger with Cyclo Therapeutics Following Shareholder Approvals - GlobeNewswire
Major Pharma Merger: Rafael Holdings Gains Phase 3 Rare Disease Asset in Strategic Deal - Stock Titan
I Would Not Short Tesla Stock at Current Valuations - The Globe and Mail
1.99%
大文字化:
|
ボリューム (24 時間):